News | October 1, 2008

Examine Dry Powder Inhalation Drugs, Devices, And Delivery Therapeutics With This Essential And Comprehensive Report

DUBLIN, Ireland --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/54a9ff/dry_powder_inhalat) has announced the addition of the "Dry Powder Inhalation - Drugs, Devices and Delivery Therapeutics" report to their offering.

The convergence of socioeconomic and technology factors – the growing emphasis on drug self-administration for chronic conditions, the expected acceleration in protein- and peptide-based therapeutics, the availability of innovative dry powder inhalation devices with unique device designs - is driving interest in pulmonary drug delivery technology and devices as an alternative to oral and parenteral routes of administration. While several approaches for delivering active substances to, and systematically via, the lungs compete in this space, recent advances and investment in powder formulations, particle engineering, and device architecture have positioned dry powder inhalers to take full advantage of these trends. The report includes comprehensive assessments of current and future dry powder inhalation, dry powder inhalation technology, industry data and forecasts, device and particle technology profiles, key alliances and partnerships, and detailed analysis of design and economic factors. The report has been organized and written to provide pharmaceutical professionals, drug delivery market participants, and supply chain companies with all of the information necessary to understand the growing impact of dry powder inhalers on drug design and development, therapeutic protocols, and healthcare economics.

Market Data

The study presents qualitative and quantitative data and information on key market measures and benchmarks:

  • Pulmonary Drug Delivery Market Segments and AGR
  • Market Dynamics and Sensitivities
  • Inhaled Drug Economic Factors
  • DPI Technology Market Potential
  • DPI Device Industry Structure
  • DPI Design Parameters
  • Third-party Stakeholders
  • Market Participant Profiles
  • Device-Pharma Alliance Activity and Deal Structure
  • Competitive Risks
  • Proprietary Technology
  • Self-Medication User Issues
  • Technology Risk Factors
  • Regulatory Risk Factors

Forecasts and projections cover the period from 2008 to 2011.

Key Topics Covered:

Executive Summary

Inhaled Drug Delivery Market Dynamics

  • Portrait of an Evolving Market
  • Established Therapeutic Targets
  • Emerging Therapies
  • Demographics and Growth
  • Competing Technologies
  • Market Drivers
  • Factors Limiting Growth

Dry Powder Inhalation Technology

  • Drug Formulations
  • Dry Powder Particle Technology
  • Particle/Powder Engineering
  • Dry Powder Formulations
  • Dry Powder Processing
  • Dry Powder Packaging
  • Emerging Formulations
  • Dry Powder Inhalers
  • DPI Device Characteristics
  • DPI Design Parameter
  • Emerging DPI Technologies

DPI Devices

  • Commercial Devices
  • Development-Stage Devices
  • Device Design Factors
  • Device Performance Factors

DPI Drug Delivery Therapeutics

  • Pulmonary Medicine
  • Asthma
  • COPD
  • Systemic Therapeutics
  • Cystic Fibrosis
  • Diabetes
  • Hormone Therapy/Replacement
  • Influenza
  • Narcotic Analgesics
  • Neurology
  • Vaccines
  • Other Potential Therapies
  • OTC Applications of DPI

Market Factors

  • FDA Regulations
  • Device Packaging
  • DPI Testing
  • Design Partnerships

Dry Powder Inhalation - Company Profiles

For more information visit http://www.researchandmarkets.com/research/54a9ff/dry_powder_inhalat

Copyright 2008 Business Wire All Rights Reserved.